Table 1 |
||
|
Demographic data of patients suffering from sepsis receiving either placebo or high-dose antithrombin therapy |
||
|
Placebo |
Antithrombin |
|
|
|
||
|
Number of patients (n) |
16 |
17 |
|
Age (years) |
56 ± 17 |
51 ± 19 |
|
Height (cm) |
175 ± 4 |
169 ± 9 |
|
Weight (kg) |
80.7 ± 22.5 |
75.9 ± 22.4 |
|
4-day survival rate (n) |
16 |
16 |
|
28-day survival rate (n) |
11 |
12 |
|
Acute Pathophysiology and Chronic Health Evaluation II score |
52 ± 9.5 |
53 ± 12.6 |
|
Low-molecular-weight heparin at inclusion (IU/day) |
6042 ± 1982 |
6388 ± 2205 |
|
|
||
|
Data presented as the mean ± standard deviation or n. |
||
|
Gonano et al. Critical Care 2006 10:R160 doi:10.1186/cc5098 |
||
